Thomas J. Appio
2021
Compensation breakdown
Non-Equity Incentive Plan | $1,202,000 |
---|---|
Option Awards | $540,009 |
Salary | $854,135 |
Stock Awards | $6,752,818 |
Other | $839,084 |
Total | $10,188,046 |
Appio received $6.8M in stock awards, accounting for 66% of the total pay in 2021.
Appio also received $1.2M in non-equity incentive plan, $540K in option awards, $854.1K in salary and $839.1K in other compensation.
Rankings
In 2021, Thomas J. Appio's compensation ranked 1,012th out of 12,415 executives tracked by ExecPay. In other words, Appio earned more than 91.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,012 | 92nd |
Manufacturing | 340 | 94th |
Chemicals And Allied Products | 114 | 95th |
Drugs | 97 | 95th |
Pharmaceutical Preparations | 65 | 96th |
Pay ratio
Thomas J. Appio's Pay | $10,188,046 |
---|---|
Median Employee's Pay | $44,617 |
Pay Ratio | 228to 1 |
In 2021, the annual total compensation of Thomas J. Appio was $10,188,046.
The annual total compensation of the median employee at Valeant Pharmaceuticals International was $44,617.
The ratio of Thomas J. Appio's pay to the pay of median employee was therefore 228 to one.
Appio's colleagues
We found five more compensation records of executives who worked with Thomas J. Appio at Valeant Pharmaceuticals International in 2021.
2021
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
2021
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
2021
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
2021
Sam Eldessouky
Valeant Pharmaceuticals International
Chief Financial Officer
2021
Robert Spurr
Valeant Pharmaceuticals International